Nurix Therapeutics
NRIX
#4925
Rank
A$2.24 B
Marketcap
$31.68
Share price
-1.05%
Change (1 day)
125.10%
Change (1 year)

Nurix Therapeutics (NRIX) - Cash on Hand

Cash on Hand as of August 2024 : A$0.71 Billion

According to Nurix Therapeutics's latest financial reports the company has A$0.71 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Nurix Therapeutics - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-11-30A$0.43 B-5.95%
2022-11-30A$0.46 B11.76%
2021-11-30A$0.41 B8.93%
2020-11-30A$0.37 B581.37%
2019-11-30A$55.75 M4.57%
2018-11-30A$53.31 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$0.43 B-39.21%๐Ÿ‡บ๐Ÿ‡ธ USA